Turning Clinical Ideas into Market Opportunities

Size: px
Start display at page:

Download "Turning Clinical Ideas into Market Opportunities"

Transcription

1 Turning Clinical Ideas into Market Opportunities Howard R. Levin, M.D. MDTX Presentation April 4, MIN

2 Goals of Presentation Explain how ideas are moved from academics to industry Explore the issues/difficulties in working with physicians Illustrate a pathway that can successfully move something from academics to commercialization Talk about what a patent is and who is an inventor to allow you to be able to protect yourself with University Tech Transfer offices 2

3 Serial Entrepreneurs with Long Track Record of Successful Innovation Founded 6 companies of our own - all already acquired, in clinical practice or in clinical trials Provided seminal IP for others products are in US/OUS sales and/or acquired by a strategic Functioned as CEO/CMO/CSO/CTO of companies while undertaking the whole cycle of device development, approval and sales We now focus on from back of the napkin to first in human / proof of concept studies 15 years of joint innovation as patents issued $100 MM funding raised >$1.4 B returned to investors 3

4 Some of Our Inventions and Companies Founded 2010, recent Series B from SVLS & TRV in 2013 Founded 2003, Acquired by Medtronic for $800mm in 2010 Seminal patents, Acquired by Abbott for $410 million in 2010 Founded 1999, Acquired by Gambro for $77 million in , Strategic Investment by Abbott & LivaNova Seminal patents, product on sale in Europe 4 CardioLogic Systems Founded 1992, Acquired by ZOLL Medical in 2004 Seminal patents, product on sale in Europe

5 Worked Both in Academics and Industry Undergrad BME (JHU) Masters in BME MD, Internal Medicine Residency Cardiology fellowship with training in HF/Transplant (JHU) Ran mechanical cardiac assist program at Columbia Really enjoyed clinical medicine but also enjoyed research, physiology, engineering and developing new ideas Left academics to join my first company 5

6 Relationship of Physicians and Engineers Relationships between physicians and industry have led to life-saving innovations, such as steerable cardiac catheters and certain artificial heart valves Physician innovators also developed the first reliable pacemakers in the 1950s and 1960s, with medical device makers later introducing additional refinements Device manufacturers considered physician to have a central role in identifying the needs for the industry 6

7 Relationship of Physicians and Engineers However, at that time, physicians on the leading edge of medical knowledge also found it necessary at first to build the tools they need Starting with the Medical Device Amendments in the 1976 and Safe Medical Device Act in 1990, physicians could not just glue things together in their basement In large part, this led to the start of the development of closer relationships between physicians and engineers Especially today, it has become increasingly important for both physicians and engineers to better understand each other and how each other works and thinks 7

8 Common Example of a Today s Physician Invention An idea is conceived by a physician no access to engineering and come up with what they think is a good approach Inventor wants to publish the early (likely preclinical) results and present them at a conference University files one U.S. or carbon copy PCT application where inventor describes the clinical implications of the idea in great detail (not patentable) and supplements it with a single hypothetical design embodiment that serves as an illustration University secures narrow claims reflecting the initial armchair design of a medical device. They now have issued claims that they will try to license When they try to get it licensed, they then get surprised by the response of industry 8

9 What Happens Then? Industry commonly finds the seminal patent disclosed an unworkable design (they did not work with an experienced engineer). However, this initial patent is now prior art that hinders later patenting Thus, the physician inventor has just prevented anyone from owning the field and locked themselves out of being able to capitalize on their specific embodiment (unless is the absolute best way to do it) Although the initial intellectual heavy lifting was done by academia, industry can ignore the seminal patent and picks up on the invention process They generate hundreds of patents disclosing more sophisticated, better engineered designs IP estate is now fragmented into multiple, often overlapping, portfolios claiming various solutions to the problem. First inventor has to be content with making but I was First statements. 9

10 Let s Say They Could Raise Enough Money to Start a Company Academic clinicians/scientists came up with an idea for a device and started a company. They found they did not understand and could not perform all of the required functions to commercialize their idea in humans Execution team was hired to make commercial device, do clinical trials, start sales, etc. Companies commonly failed after this transition because of gap that exists in translating scientific, clinical, market, etc. issues to execution teams Lead to the development of incubators that helped to bridge this gap GAP Research/Clinical Concept Team INCUBATOR Execution Team Sales and Marketing Team 10

11 Physician Standard Device Idea Assessment Process They have been working on an idea that has been NIH/other funded for several years it looks like it works well in animals and may have clinical benefit While placing stents, they notice that if the catheter they used had a specific curve, some of your hardest cases would become faster and easier They noticed that if pacemakers implemented your new stimulation algorithm, it would improve cardiac output in your most difficult patients Are these good ideas? How do you tell which it is? For Mankind, Yes. For a Business, Maybe 11

12 Mankind vs. Business Things that are a business means that there are enough patients to use it in, simple enough to use widely in those patients and can be developed in an appropriate amount of time and money invested for the investor to make a return on their investment Fundable Fundable ~ It works great clinically and I personally need it frequently How much better your device therapy is than existing ones How hot your idea, specifically at the time you shop it Finding the 1 in 10 VCs that already believe in concept How good a job you do presenting a rational plan How lucky you are to be at the right place at the right time Things that are good for mankind are primarily funded by NIH/Foundation/ other non-profit sources of money Things that are businesses are funded by VCs or strategics: How should one choose what ideas to work on? 12

13 How Do Doctors Approach This Very hard for a clinician or scientist to competently evaluate all of the marketing, clinical, engineering, IP, reimbursement, regulatory, etc. on their own Just not trained/have the experience to do all of the required tasks well They need to: Partner with someone/group of people who has already been through it License to incubator take royalties So, what areas should physicians be focused on 13

14 Breakthrough Therapies Tend To Start In Academics/ Better Tools Developed In Industry or By Clinicians 14

15 What Should You Know Before You Decide to Move Ahead With Starting A Company Issue Unmet Clinical Need and Therapy Goal Physiological Mechanism Initial Device Design Description What is the specific clinical indication we are going after What overall clinical benefit are we trying to achieve Is there a known but unexploited physiological mechanism that will allow one to address an unmet clinical need that is a drug failure Is there at least one potential device design that can be used to implement our proposed therapy Proposed Technology/ Technical Risk Do you have to develop a totally new approach. Can we repurpose some existing technology? Can you limit the novel issues (every risk) to < XX% of the project Clinical and Regulatory Risk Is there a known trial design or are you the first to work in this area Number of patients required Inclusion/exclusion criteria What measurable and accepted clinical and/or physiological endpoints exist in both the shortterm (immediate to 3 months) and long-term (3 months to 2+ years) that will justify moving ahead with the study, continued funding or future acquisition Required duration of follow-up IP Risk Reimbursement What is potential to own therapeutic space and core or enabling technologies Freedom to Practice Is our device novel Does it exist, can we piggyback on existing reimbursement 15

16 What Should You Know Before You Decide to Move Ahead With Starting A Company Issue Time From Idea to Approval Sales and Marketing Risks Exit Strategy Potential for early investment/exit Description How long before you get acquired or become cash flow positive Is that an acceptable Return On Investment (ROI) for your potential investors For each of the indication(s), what is the base and maximum market size and what factors are related to that Who are the potential users of the proposed embodiment(s) How does it fit their existing skill set? Who owns the patient Is it a normal referral pathway between the user and referrer? Who are the logical acquirers for the proposed therapy What information would be needed by the acquirers to make an early strategic investment or acquisition possible and when would that data be available Need for sales ramp to exit Does the proposed therapy need to enter sales to be acquired Within our core competence Key Issues to resolve Potential for early risk reduction Is the proposed therapy within our existing expertise or are we comfortable extending to that clinical area because of the overlap of physiological expertise What are the major issues that need to be resolved prior to starting moving to next phase of preclinical trials, basic embodiment development/testing, etc.? What can be done to quickly reduce risk? What logical milestones exist for company financing? 16

17 Important Take Away Points Comparatively easy to come up with an idea that if it works, will have a significant impact on the clinical care of patients Very hard to find a commercially viable project that will meet all the criteria necessary for success Synergy of physicians and engineers is essential. Working with an experienced team helps a lot. Use physician input to reduce both physiologic & clinical risk Provide engineering input to avoid physicians trying to break the laws of physics such as asking you to make a catheter that has an inside diameter bigger that the outside diameter 17

18 What Is A Patent? Historic need to protect and preserve trade secrets was already recognized in ancient Greece Royal patents were given to craftsmen during the time of the plague granting them monopoly for period of time in return for sharing trade secrets Republic of Florence gave architect Filippo Brunelleschi a three-year patent for a barge with hoisting gear, that carried marble along the Arno River in 1421 Dual nature of patent law: protect the inventor from copycat competitors & protect public from being abused by the monopolist Resolved by limiting scope and time of the patent Even today fundamentals didn t change. Scope of the monopoly is negotiated with the Patent Office and life of patent is set to 20 years 18

19 What Patent Does And Doesn t Do It does not give inventor rights to manufacture and sell the covered product Gives inventor rights to exclude others Thus, first and foremost: inventors need to understand the IP landscape think real estate What is owned by them, owned by others, owned by community? Patents are bought, sold and rented like any other property Inventorship is a legal definition while ownership is contractual not necessarily related 19

20 What Is Patentable? Devices, processes and methods (in the US only) Abstract ideas and scientific discoveries of natural phenomena are not patentable need some reduction to practice/ be enabled Of paramount importance are the concepts of novelty and non-obviousness Novelty is relatively self explanatory and well defined. You cannot invent something that already exists. Obviousness is defined by invoking a ordinary person skilled in the art. Imagine a fresh BME graduate armed with library card but not inventive. Would it be obvious to him to combine all the elements? 20

21 Invention Favors the Prepared Mind Look for surprising, counterintuitive results in your experiments and record them Work with your counsel to write the specification while avoiding many obviousness pitfalls If your patent is valuable, its obviousness will be challenged by competitors with 100% probability! 21

22 What Makes You An Inventor? Contribution to conception and reduction to practice of the claim Merely assisting in reduction to practice (such as giving information you could find in the literature or providing resources/effort) is not inventorship Common reasons for patent invalidation: claiming invention by somebody else, not including a contributor Bottom line: Inventorship is defined in legal terms and is better left to your legal team. Work with them closely 22

23 Summary Physicians have the ability to identify unmet clinical needs or improvements They do not have the ability to develop those ideas into a practical device Don t believe their propaganda kill projects quickly, even if they have some exceptional strengths. To get funded you need to answer all questions with YES Do find and learn to work with physicians who are willing to use a structured approach to device development 23

Turning Clinical Ideas into Market Opportunities Howard Levin: Goals of Presentation

Turning Clinical Ideas into Market Opportunities Howard Levin: Goals of Presentation Turning Clinical Ideas into Market Opportunities presented April 4, 2018 by Dr. Howard Levin, President and CSO, Coridea at MDTX, the Medical Device Technology Exchange Howard Levin: I'm going to talk

More information

IP For Entrepreneurs. For Background Education Only NOT LEGAL ADVICE

IP For Entrepreneurs. For Background Education Only NOT LEGAL ADVICE For Background Education Only NOT LEGAL ADVICE Great Dome Associates www.great-dome.com IP For Entrepreneurs Joe Hadzima (MIT S.B., M.Sc. in Management; J.D. Harvard Law) Senior Lecturer, MIT Sloan School

More information

Intellectual Property and UW Technology Transfer. Patrick Shelby, PhD Technology Manager October 26, 2010

Intellectual Property and UW Technology Transfer. Patrick Shelby, PhD Technology Manager October 26, 2010 Intellectual Property and UW Technology Transfer Patrick Shelby, PhD Technology Manager October 26, 2010 Topics Introduction to IP The invention process at UW Anatomy of a patent The Invention Disclosure

More information

RANDI L. KARPINIA SENIOR PATENT OPERATIONS COUNSEL LAW DEPARTMENT, MOTOROLA SOLUTIONS INC.

RANDI L. KARPINIA SENIOR PATENT OPERATIONS COUNSEL LAW DEPARTMENT, MOTOROLA SOLUTIONS INC. RANDI L. KARPINIA SENIOR PATENT OPERATIONS COUNSEL LAW DEPARTMENT, MOTOROLA SOLUTIONS INC. Patent Basics Should all new ideas be patented? Why do patents matter? When should a patent application be filed?

More information

Practical Strategies for Biotechnology and Medical Device Companies to Manage Intellectual Property Rights

Practical Strategies for Biotechnology and Medical Device Companies to Manage Intellectual Property Rights Practical Strategies for Biotechnology and Medical Device Companies to Manage Intellectual Property Rights Matt Jonsen Dorsey & Whitney LLP Angie Morrison Dorsey & Whitney LLP Intellectual Property Patents

More information

Getting Started. This Lecture

Getting Started. This Lecture Getting Started Entrepreneurship (MGT-271) Lecture 9-11 This Lecture Intellectual Property Rights Forms of intellectual property Patent, its types and steps to obtaining patent Potential financing sources

More information

Introduction to Intellectual Property

Introduction to Intellectual Property Introduction to Intellectual Property Jeremy Nelson, PhD Licensing Manager & Patent Agent Technology Transfer Office CSURF What is intellectual property? Any product of the human intellect that is unique,

More information

Effective Intellectual Property Management

Effective Intellectual Property Management Effective Intellectual Property Management Tom Smerdon Director, Licensing and New Business Development tom.smerdon@cu.edu NSF PV Workshop Golden, CO May 6, 2010 Knowledge Innovation Technology University

More information

Discovery: From Concept to the Patient - The Business of Medical Discovery. Todd Sherer, Ph.D.

Discovery: From Concept to the Patient - The Business of Medical Discovery. Todd Sherer, Ph.D. Discovery: From Concept to the Patient - The Business of Medical Discovery Todd Sherer, Ph.D. Associate Vice President for Research and Director of OTT President Elect, Association of University Technology

More information

Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond

Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond ACI Forum on Structuring, Negotiating and Managing Life Sciences Collaborations and Acquisitions February 28,

More information

Patent Due Diligence

Patent Due Diligence Patent Due Diligence By Charles Pigeon Understanding the intellectual property ("IP") attached to an entity will help investors and buyers reap the most from their investment. Ideally, startups need to

More information

Intellectual Property

Intellectual Property What is Intellectual Property? Intellectual Property Introduction to patenting and technology protection Jim Baker, Ph.D. Registered Patent Agent Director Office of Intellectual property can be defined

More information

WIPO REGIONAL SEMINAR ON SUPPORT SERVICES FOR INVENTORS, VALUATION AND COMMERCIALIZATION OF INVENTIONS AND RESEARCH RESULTS

WIPO REGIONAL SEMINAR ON SUPPORT SERVICES FOR INVENTORS, VALUATION AND COMMERCIALIZATION OF INVENTIONS AND RESEARCH RESULTS ORIGINAL: English DATE: November 1998 E TECHNOLOGY APPLICATION AND PROMOTION INSTITUTE WORLD INTELLECTUAL PROPERTY ORGANIZATION WIPO REGIONAL SEMINAR ON SUPPORT SERVICES FOR INVENTORS, VALUATION AND COMMERCIALIZATION

More information

UHS Intellectual Property Policies and Procedures

UHS Intellectual Property Policies and Procedures UHS Intellectual Property Policies and Procedures Office of Intellectual Property Management Email: oipm@central.uh.edu Importance of IP Exclusive rights - exclude others from making, using or selling

More information

Collaborating with the Office of Technology Transfer

Collaborating with the Office of Technology Transfer Collaborating with the Office of Technology Transfer Todd Sherer, Ph.D. Associate Vice President for Research and Executive Director Office of Technology Transfer Emory Owns Our IP As a condition of employment,

More information

Topic 3 - Chapter II.B Primary consideration before drafting a patent application. Emmanuel E. Jelsch European Patent Attorney

Topic 3 - Chapter II.B Primary consideration before drafting a patent application. Emmanuel E. Jelsch European Patent Attorney Topic 3 - Chapter II.B Primary consideration before drafting a patent application Emmanuel E. Jelsch European Patent Attorney Table of Contents Detailed Overview of Patents Patent Laws Patents Overview

More information

TECHNOLOGY TRANSFER AT THE UNIVERSITY OF TENNESSEE: INVENTIONS AND COMMERCIALIZATION

TECHNOLOGY TRANSFER AT THE UNIVERSITY OF TENNESSEE: INVENTIONS AND COMMERCIALIZATION utrf@tennessee.com TECHNOLOGY TRANSFER AT THE UNIVERSITY OF TENNESSEE: INVENTIONS AND COMMERCIALIZATION Hot Topics in Research, May 23, 2017 Richard Magid, PhD UTRF Vice President WHAT IS TECHNOLOGY TRANSFER?

More information

ECU Research Commercialisation

ECU Research Commercialisation The Framework This framework describes the principles, elements and organisational characteristics that define the commercialisation function and its place and priority within ECU. Firstly, care has been

More information

Patents. What is a patent? What is the United States Patent and Trademark Office (USPTO)? What types of patents are available in the United States?

Patents. What is a patent? What is the United States Patent and Trademark Office (USPTO)? What types of patents are available in the United States? What is a patent? A patent is a government-granted right to exclude others from making, using, selling, or offering for sale the invention claimed in the patent. In return for that right, the patent must

More information

Data Sciences Entrepreneurship class

Data Sciences Entrepreneurship class Data Sciences Entrepreneurship class Feb 2013 @Columbia_Tech Columbia Technology Ventures Columbia Technology Ventures www.techventures.columbia.edu techventures@columbia.edu Agenda for Today 1. Context

More information

WPI Intellectual Property A day in the life of the tech transfer office. Todd Keiller Director, Intellectual Property and Innovation

WPI Intellectual Property A day in the life of the tech transfer office. Todd Keiller Director, Intellectual Property and Innovation WPI Intellectual Property A day in the life of the tech transfer office Todd Keiller Director, Intellectual Property and Innovation Who does research? Federal and state governments Defense, public health,

More information

Key issues in building a strong life sciences patent portfolio. Tom Harding and Jane Wainwright Potter Clarkson LLP

Key issues in building a strong life sciences patent portfolio. Tom Harding and Jane Wainwright Potter Clarkson LLP Key issues in building a strong life sciences patent portfolio Tom Harding and Jane Wainwright Potter Clarkson LLP SECURING INNOVATION PATENTS TRADE MARKS DESIGNS Award winning, expert intellectual property

More information

Patents An Introduction for Owners

Patents An Introduction for Owners Patents An Introduction for Owners Outline Review of Patents What is a Patent? Claims: The Most Important Part of a Patent! Getting a Patent Preparing Invention Disclosures Getting Inventorship Right Consolidating

More information

Research Patents in Biotech SMEs

Research Patents in Biotech SMEs Research Patents in Biotech SMEs Doorways, Obstacles, Fortifications & Bridges Neil Thomas PhD Director of Intellectual Property, Genetrix Group, Madrid, Spain. Agenda 1. Introduction to Genetrix Definition

More information

5/30/2018. Prof. Steven S. Saliterman Department of Biomedical Engineering, University of Minnesota

5/30/2018. Prof. Steven S. Saliterman Department of Biomedical Engineering, University of Minnesota Department of Biomedical Engineering, University of Minnesota http://saliterman.umn.edu/ Protect technology/brand/investment. Obtain financing. Provide an asset to increase the value of a company. Establish

More information

Technology Transfer and the University: an orientation for new faculty at Johns Hopkins University

Technology Transfer and the University: an orientation for new faculty at Johns Hopkins University Johns Hopkins Technology Transfer Bringing the benefits of discovery to the World. Technology Transfer and the University: an orientation for new faculty at Johns Hopkins University Wesley D. Blakeslee,

More information

The IP Landscape for Combination Products

The IP Landscape for Combination Products The IP Landscape for Combination Products MassMEDIC Seminar March 3, 2011 presented by Jason Honeyman Wolf, Greenfield & Sacks, P.C. 600 Atlantic Avenue Boston, Massachusetts 02210 617.646.8000 617.646.8646

More information

Evaluating a Report of Invention & Licensing. Technology Development Boot Camp Peter Liao March 25, 2013

Evaluating a Report of Invention & Licensing. Technology Development Boot Camp Peter Liao March 25, 2013 Evaluating a Report of Invention & Licensing Technology Development Boot Camp Peter Liao March 25, 2013 Technology Transfer at UNC Is. The process of forming partnerships with industry for the purpose

More information

Patent Law: What Anesthesiologists Should Know

Patent Law: What Anesthesiologists Should Know Patent Law: What Anesthesiologists Should Know Kirk Hogan MD, JD ISAP 23 rd Annual Meeting October 10, 2014 khogan@wisc.edu, kjhogan@casimirjones.com How Nobody Invented Anesthesia (J. M. Fenster, American

More information

THE AMERICA INVENTS ACT NEW POST-ISSUANCE PATENT OFFICE PROCEEDINGS

THE AMERICA INVENTS ACT NEW POST-ISSUANCE PATENT OFFICE PROCEEDINGS THE AMERICA INVENTS ACT NEW POST-ISSUANCE PATENT OFFICE PROCEEDINGS By Sharon Israel and Kyle Friesen I. Introduction The recently enacted Leahy-Smith America Invents Act ( AIA ) 1 marks the most sweeping

More information

Translational scientist competency profile

Translational scientist competency profile C-COMEND Competency profile for Translational Scientists C-COMEND is a two-year European training project supported by the Erasmus plus programme, which started on November 1st 2015. The overall objective

More information

Patent application strategy when, where, what to file?

Patent application strategy when, where, what to file? Patent application strategy when, where, what to file? Dominique Winne Examiner (ICT) 7 November 2017 Contents IP strategy When, where, and what to file Relevant aspects for filing strategy 2 1 The four

More information

Prof. Steven S. Saliterman. Department of Biomedical Engineering, University of Minnesota

Prof. Steven S. Saliterman. Department of Biomedical Engineering, University of Minnesota Department of Biomedical Engineering, University of Minnesota http://saliterman.umn.edu/ Protect technology/brand/investment. Obtain financing. Provide an asset to increase the value of a company. Establish

More information

Patents and Intellectual Property

Patents and Intellectual Property Patents and Intellectual Property Teaching materials to accompany: Product Design and Development Chapter 16 Karl T. Ulrich and Steven D. Eppinger 5th Edition, Irwin McGraw-Hill, 2012. Value of Intellectual

More information

Technology Commercialization Primer: Understanding the Basics. Leza Besemann

Technology Commercialization Primer: Understanding the Basics. Leza Besemann Technology Commercialization Primer: Understanding the Basics Leza Besemann 10.02.2015 Agenda Technology commercialization a. Intellectual property b. From lab to market Patents Commercialization strategy

More information

Invention SUBMISSION BROCHURE PLEASE READ THE FOLLOWING BEFORE SUBMITTING YOUR INVENTION

Invention SUBMISSION BROCHURE PLEASE READ THE FOLLOWING BEFORE SUBMITTING YOUR INVENTION Invention SUBMISSION BROCHURE PLEASE READ THE FOLLOWING BEFORE SUBMITTING YOUR INVENTION The patentability of any invention is subject to legal requirements. Among these legal requirements is the timely

More information

Practical Strategies for Managing Patent Rights for Biotechnology and Medical Device Companies

Practical Strategies for Managing Patent Rights for Biotechnology and Medical Device Companies Practical Strategies for Managing Patent Rights for Biotechnology and Medical Device Companies Timothy A. Worrall, Ph.D. Partner Dorsey & Whitney LLP Brad J. Hattenbach Of Counsel Dorsey & Whitney LLP

More information

Berkeley Postdoc Entrepreneur Program (BPEP)

Berkeley Postdoc Entrepreneur Program (BPEP) Berkeley Postdoc Entrepreneur Program (BPEP) BPEP Mission: To foster entrepreneurship in the UC Berkeley postdoctoral and scientific community in order to move innovations from the laboratory to the marketplace.

More information

Building a Competitive Edge: Protecting Inventions by Patents and Utility Models

Building a Competitive Edge: Protecting Inventions by Patents and Utility Models Topic 4 Building a Competitive Edge: Protecting Inventions by Patents and Utility Models Training of Trainer s Program, Teheran 8 June 2015 By Matthias Kuhn, MBA University of Geneva, Unitec, Switzerland

More information

Valerie S. Gaydos Angel Investor President, Capital Growth, Inc. How Proposed Patent Reform Increases Risk for Start-Up Investors

Valerie S. Gaydos Angel Investor President, Capital Growth, Inc. How Proposed Patent Reform Increases Risk for Start-Up Investors Valerie S. Gaydos Angel Investor President, Capital Growth, Inc. How Proposed Patent Reform Increases Risk for Start-Up Investors August 30, 2011 Valerie S. Gaydos Serial Entrepreneur Angel Investor: Angel

More information

Mike Hess Vice President, Innovation Medtronic Inc

Mike Hess Vice President, Innovation Medtronic Inc Mike Hess Vice President, Innovation Medtronic Inc Medtronic Today World headquarters Minneapolis European headquarters Lausanne Asia/Pacific headquarters Singapore $40-60 Billion market capitalization

More information

The 9 Sources of Innovation: Which to Use?

The 9 Sources of Innovation: Which to Use? The 9 Sources of Innovation: Which to Use? By Kevin Closson, Nerac Analyst Innovation is a topic fraught with controversy and conflicting viewpoints. Is innovation slowing? Is it as strong as ever? Is

More information

Prof. Steven S. Saliterman. Department of Biomedical Engineering, University of Minnesota

Prof. Steven S. Saliterman. Department of Biomedical Engineering, University of Minnesota Department of Biomedical Engineering, University of Minnesota http://saliterman.umn.edu/ Process by which new innovations flow from the basic research bench to commercial entities and then to public use.

More information

An investment in a patent for your invention could be the best investment you will ever

An investment in a patent for your invention could be the best investment you will ever San Francisco Reno Washington D.C. Beijing, China PATENT TRADEMARK FUNDING BROKER INVENTOR HELP Toll Free: 1-888-982-2927 San Francisco: 415-515-3005 Facsimile: (775) 402-1238 Website: www.bayareaip.com

More information

As a Patent and Trademark Resource Center (PTRC), the Pennsylvania State University Libraries has a mission to support both our students and the

As a Patent and Trademark Resource Center (PTRC), the Pennsylvania State University Libraries has a mission to support both our students and the This presentation is intended to help you understand the different types of intellectual property: Copyright, Patents, Trademarks, and Trade Secrets. Then the process and benefits of obtaining a patent

More information

Diego Braguglia General partner di IV Partners. Claudio Nessi. Esperienza di Venture Capital. Managing partner di Neomed

Diego Braguglia General partner di IV Partners. Claudio Nessi. Esperienza di Venture Capital. Managing partner di Neomed Diego Braguglia General partner di IV Partners Claudio Nessi Managing partner di Neomed Esperienza di Venture Capital 15 anni d esperienza di Venture Capital in Svizzera... e in Ticino Diego Braguglia

More information

Teaching engineering-based new product innovation and entrepreneurship to engineers and business professionals

Teaching engineering-based new product innovation and entrepreneurship to engineers and business professionals Teaching engineering-based new product innovation and entrepreneurship to engineers and business professionals Paul Swamidass (swamidas@auburn.edu) (211 Ramsey Hall, Auburn University, Auburn, AL 36832;

More information

AN OVERVIEW OF THE UNITED STATES PATENT SYSTEM

AN OVERVIEW OF THE UNITED STATES PATENT SYSTEM AN OVERVIEW OF THE UNITED STATES PATENT SYSTEM (Note: Significant changes in United States patent law were brought about by legislation signed into law by the President on December 8, 1994. The purpose

More information

The Inventor s Role: Understanding the Technology Transfer Process

The Inventor s Role: Understanding the Technology Transfer Process The Inventor s Role: Understanding the Technology Transfer Process Phillip Owh, Sr. Technology Licensing Officer Martin Teschl, Sr. Technology Licensing Officer Topics University Technology Transfer What

More information

Commercialization Workshop Series Commercialization Pathways. April 2, 2015

Commercialization Workshop Series Commercialization Pathways. April 2, 2015 Commercialization Workshop Series Commercialization Pathways April 2, 2015 Commercialization Workshop Series Commercialization Pathways Commercialization Options Parasight Seikowave Dean Harvey Eric Hauck

More information

Intellectual Property

Intellectual Property Intellectual Property Technology Transfer and Intellectual Property Principles in the Conduct of Biomedical Research Frank Grassler, J.D. VP For Technology Development Office for Technology Development

More information

Contents. 1 Introduction... 1

Contents. 1 Introduction... 1 Contents 1 Introduction... 1 Part I Startup Funding Sources, Stages of the Life Cycle of a Business, and the Corresponding Intellectual Property Strategies for Each Stage 2 Sources of Company Funding...

More information

The Transition to Model-Based Drug Development. Phase 1: Formalizing the Pharmacometric Process

The Transition to Model-Based Drug Development. Phase 1: Formalizing the Pharmacometric Process 1780 Wehrle Drive Suite 110 Buffalo, New York 14221 716.633.3463 cognigencorp.com The Transition to Model-Based Drug Development Phase 1: Formalizing the Pharmacometric Process By Thaddeus H. Grasela,

More information

Introduction Disclose at Your Own Risk! Prior Art Searching - Patents

Introduction Disclose at Your Own Risk! Prior Art Searching - Patents Agenda Introduction Disclose at Your Own Risk! Prior Art Searching - Patents Patent Basics Understanding Different Types of Searches Tools / Techniques for Performing Searches Q&A Searching on Your Own

More information

Key Strategies for Your IP Portfolio

Key Strategies for Your IP Portfolio Key Strategies for Your IP Portfolio Jeremiah B. Frueauf, Partner Where s the value?! Human capital! Physical assets! Contracts, Licenses, Relationships! Intellectual Property Patents o Utility, Design

More information

UNCTAD Ad Hoc Expert Meeting on the Green Economy: Trade and Sustainable Development Implications November

UNCTAD Ad Hoc Expert Meeting on the Green Economy: Trade and Sustainable Development Implications November UNCTAD Ad Hoc Expert Meeting on the Green Economy: Trade and Sustainable Development Implications 8-10 November Panel 3: ENHANCING TECHNOLOGY ACCESS AND TRANSFER Good morning Ladies and Gentlemen. On behalf

More information

Sponsored by WIPO, JPO, and IPOPHL Manila, 29 February 2016

Sponsored by WIPO, JPO, and IPOPHL Manila, 29 February 2016 National Workshop on Increasing the Capacity and Pace for Technology Scouting, Absorption, Adaptation through a Hub and Spoke Structure (IP Hub) Sponsored by WIPO, JPO, and IPOPHL Manila, 29 February 2016

More information

Trade Secret Protection of Inventions

Trade Secret Protection of Inventions Trade Secret Protection of Inventions Phil Marcoux & Kevin Roe Inventions - Trade Secret or Patent? Theft by employees, executives, partners Theft by contract Note - this class does not create an attorney-client

More information

Technology Transfer and Intellectual Property Best Practices

Technology Transfer and Intellectual Property Best Practices Technology Transfer and Intellectual Property Best Practices William W. Aylor M.S., J.D. Director, Technology Transfer Office Registered Patent Attorney Presentation Outline I. The Technology Transfer

More information

Intellectual Property Policy. DNDi POLICIES

Intellectual Property Policy. DNDi POLICIES Intellectual Property Policy DNDi POLICIES DNDi hereby adopts the following intellectual property (IP) policy: I. Preamble The mission of DNDi is to develop safe, effective and affordable new treatments

More information

Patent protection of inventions

Patent protection of inventions Patent protection of inventions Prof. Dr. Ing. Stefan Stefanov Dr. Ing. Sanel Purgić Technical University Sofia, Faculty of German Engineering Education and Industrial Management (FDIBA) Jahorina, December

More information

Technology Transfer & Inventing in Academia

Technology Transfer & Inventing in Academia Technology Transfer & Inventing in Academia Markey Pathway Students August 28, 2014 Nichole R. Mercier, Ph.D. Associate Director, Office of Technology Management http://otm.wustl.edu Office of Technology

More information

HOW TO READ A PATENT. To Understand a Patent, It is Essential to be able to Read a Patent. ATIP Law 2014, All Rights Reserved.

HOW TO READ A PATENT. To Understand a Patent, It is Essential to be able to Read a Patent. ATIP Law 2014, All Rights Reserved. To Understand a Patent, It is Essential to be able to Read a Patent ATIP Law 2014, All Rights Reserved. Entrepreneurs, executives, engineers, venture capital investors and others are often faced with important

More information

Patent (novel, non-obvious and useful) vs. Innovate Yes - we CAN do both! The 2015 ASQ Innovation Conference September 19-20

Patent (novel, non-obvious and useful) vs. Innovate Yes - we CAN do both! The 2015 ASQ Innovation Conference September 19-20 Patent (novel, non-obvious and useful) vs. Innovate Yes - we CAN do both! The 2015 ASQ Innovation Conference September 19-20 Invention (Patent) vs. Innovation Education vs. Training Can we start with this

More information

Angel Financing. UNCP Entrepreneurial Summit UNCP Regional Center at COMtech Pembroke, NC 12 March Presented by:

Angel Financing. UNCP Entrepreneurial Summit UNCP Regional Center at COMtech Pembroke, NC 12 March Presented by: Angel Financing UNCP Entrepreneurial Summit UNCP Regional Center at COMtech Pembroke, NC 12 March 2009 Presented by: Ronald J Podraza Carolina Beach, NC Several Types of Angels Several Types of Angels

More information

PRECISE MEDICAL Self-revealing case Handout #1

PRECISE MEDICAL Self-revealing case Handout #1 OBEA Conference May 23-24, 2015 Entrepreneurship as it Relates to Financial Literacy Grant Russell, Associate Director of Undergraduate Programs School of Accounting and Finance, University of Waterloo

More information

Intellectual Property

Intellectual Property Intellectual Property Leza Besemann, Technology Strategy Manager 03.07.2012 ME 4054 Agenda Types of IP Patents a. Types b. Requirements c. Anatomy d. New US patent law About Office for Technology Commercialization

More information

Funding & Patents. Enterprise & Project Management

Funding & Patents. Enterprise & Project Management Funding & Patents Enterprise & Project Management Please note that these slides are not intended as a substitute to reading the recommended text for this course. 0 Companies that received VC funding 1

More information

Essentials of Start-Up Law

Essentials of Start-Up Law Essentials of Start-Up Law University of California, San Diego Entrepreneurship Series May 2017 Matt Bresnahan, Patent Attorney WSGR Donna Shaw, Assistant Director, Life Science Licensing Shihong Nicolaou,

More information

CDP-EIF ITAtech Equity Platform

CDP-EIF ITAtech Equity Platform CDP-EIF ITAtech Equity Platform New financial instruments to support technology transfer in Italy TTO Circle Meeting, Oxford June 22nd 2017 June, 2017 ITAtech: the "agent for change" in TT landscape A

More information

Patenting Strategies. The First Steps. Patenting Strategies / Bernhard Nussbaumer, 12/17/2009 1

Patenting Strategies. The First Steps. Patenting Strategies / Bernhard Nussbaumer, 12/17/2009 1 Patenting Strategies The First Steps Patenting Strategies / Bernhard Nussbaumer, 12/17/2009 1 Contents 1. The pro-patent era 2. Main drivers 3. The value of patents 4. Patent management 5. The strategic

More information

Saying. I Do to a. Franchise

Saying. I Do to a. Franchise Saying I Do to a Franchise 1 Saying I Do To A Franchise Like marriage, buying a franchise is a long-term commitment. Before you say yes, make sure you understand what it takes to be successful. The Commitment

More information

Triton Technology Fund

Triton Technology Fund Triton Technology Fund Presentation to Dean s Engineering Council March 22, 2013 Generate Returns for LPs/GPs Motivation for Fund Catalyze translation of UCSD discoveries for the benefit of society Enable

More information

Inventions, Patents, and Working with Companies. March 3, 2011 Presented by Ken Holroyd

Inventions, Patents, and Working with Companies. March 3, 2011 Presented by Ken Holroyd Inventions, Patents, and Working with Companies March 3, 2011 Presented by Ken Holroyd Patents directly provided for in the U.S. Constitution Why? The United States Patent System Government sponsored

More information

Protect your ideas. An introduction to patents for students of natural sciences, engineering, medicine and business administration

Protect your ideas. An introduction to patents for students of natural sciences, engineering, medicine and business administration Protect your ideas An introduction to patents for students of natural sciences, engineering, medicine and business administration Learning goals Understand what intellectual property is about Balance the

More information

INTELLECTUAL PROPERTY OVERVIEW. Patrícia Lima

INTELLECTUAL PROPERTY OVERVIEW. Patrícia Lima INTELLECTUAL PROPERTY OVERVIEW Patrícia Lima October 14 th, 2015 Intellectual Property INDUSTRIAL PROPERTY (INPI) COPYRIGHT (IGAC) It protects technical and aesthetical creations, and trade distinctive

More information

International Intellectual Property Practices

International Intellectual Property Practices International Intellectual Property Practices FOR: Hussein Akhavannik حسين اخوان نيك Managing Partner International IP Group, LLC Web: www.intlip.com Email: akhavannik@intlip.com Mobile: 0912-817-2669

More information

Intellectual Property Ownership and Disposition Policy

Intellectual Property Ownership and Disposition Policy Intellectual Property Ownership and Disposition Policy PURPOSE: To provide a policy governing the ownership of intellectual property and associated University employee responsibilities. I. INTRODUCTION

More information

Intellectual Property

Intellectual Property Intellectual Property Johnson & Johnson believes that the protection of intellectual property (IP) is essential to rewarding innovation and promoting medical advances. We are committed: to raising awareness

More information

Identifying and Managing Joint Inventions

Identifying and Managing Joint Inventions Page 1, is a licensing manager at the Wisconsin Alumni Research Foundation in Madison, Wisconsin. Introduction Joint inventorship is defined by patent law and occurs when the outcome of a collaborative

More information

FASTER - SAFER - BETTER

FASTER - SAFER - BETTER FASTER - SAFER - BETTER From innovators to standard of care Insights on novel technology introductions in cardiac electrophysiology from world-leading experts Summary of Scientific Program Symposium Friday

More information

PATENTING. T Technology Management in the Telecommunications Industry Aalto University

PATENTING. T Technology Management in the Telecommunications Industry Aalto University PATENTING T-109.5410 Technology Management in the Telecommunications Industry Aalto University 15.10.2013 PhD Yrjö Raivio Patent Examiner National Board of Patents and Registration of Finland (PRH) yrjo.raivio@prh.fi

More information

University IP and Technology Management. University IP and Technology Management

University IP and Technology Management. University IP and Technology Management University IP and Technology Management Yumiko Hamano WIPO University Initiative Program Innovation Division WIPO WIPO Overview IP and Innovation University IP and Technology Management Institutional IP

More information

Patent Basics for Inventors, Entrepreneurs, and Start-ups

Patent Basics for Inventors, Entrepreneurs, and Start-ups Patent Basics for Inventors, Entrepreneurs, and Start-ups Daniel Kolker, Ph.D. Supervisory Patent Examiner United States Patent and Trademark Office Daniel.Kolker@USPTO.gov Outline Why Patents? Types of

More information

CS 4984 Software Patents

CS 4984 Software Patents CS 4984 Software Patents Ross Dannenberg Rdannenberg@bannerwitcoff.com (202) 824-3153 Patents I 1 How do you protect software? Copyrights Patents Trademarks Trade Secrets Contract Technology (encryption)

More information

Exploitation strategies of IP Rights deriving from H2020 projects

Exploitation strategies of IP Rights deriving from H2020 projects Exploitation strategies of IP Rights deriving from H2020 projects Dr. Eugene Sweeney Oxford 11th/12th September 2014 Get your ticket to innovation. Understand the landscape Strategic Intelligence to develop

More information

ACCOUNTING TREATMENT OF INTELLECTUAL PROPERTY IN THE PHARMACEUTICAL INDUSTRY

ACCOUNTING TREATMENT OF INTELLECTUAL PROPERTY IN THE PHARMACEUTICAL INDUSTRY Trakia Journal of Sciences, Vol. 9, No 4, pp 63-68, 2011 Copyright 2011 Trakia University Available online at: http://www.uni-sz.bg ISSN 1313-7069 (print) ISSN 1313-3551 (online) Original Contribution

More information

Outline 3/16/2018. Patent Basics for Inventors, Entrepreneurs, and Start-ups.

Outline 3/16/2018. Patent Basics for Inventors, Entrepreneurs, and Start-ups. Patent Basics for Inventors, Entrepreneurs, and Start-ups innovationdevelopment@uspto.gov Outline Why Patents? Types of Patents Patent Examiner Duty Understanding Obviousness Patent Examination Process

More information

Data Acquisition, Management, Sharing and Ownership

Data Acquisition, Management, Sharing and Ownership Data Acquisition, Management, Sharing and Ownership University of Ibadan MEPI-J program 1 What are data? Research Data are ".. the recorded factual material commonly accepted in the scientific community

More information

Considerations for Intellectual Property Protection & at a University. Commercialization of Research

Considerations for Intellectual Property Protection & at a University. Commercialization of Research Considerations for Intellectual Property Protection & Commercialization of Research at a University By Jesse Goodwin, PhD MUSC Foundation for Research Development & SCTR Institute Questions to be Answered

More information

What s in the Spec.?

What s in the Spec.? What s in the Spec.? Global Perspective Dr. Shoichi Okuyama Okuyama & Sasajima Tokyo Japan February 13, 2017 Kuala Lumpur Today Drafting a global patent application Standard format Drafting in anticipation

More information

Innovation Office. Intellectual Property at the Nelson Mandela University: A Brief Introduction. Creating value for tomorrow

Innovation Office. Intellectual Property at the Nelson Mandela University: A Brief Introduction. Creating value for tomorrow Innovation Office Creating value for tomorrow PO Box 77000 Nelson Mandela University Port Elizabeth 6031 South Africa www.mandela.ac.za Innovation Office Main Building Floor 12 041 504 4309 innovation@mandela.ac.za

More information

Geneva, November 10-14, Topic 2: Patents

Geneva, November 10-14, Topic 2: Patents WIPO-MOST Intermediate Training Course on Practical Intellectual Property Issues in Business Geneva, November 10-14, 2003 Topic 2: Patents I. Introduction to the patent system 1. What do you imagine when

More information

Preparing Your Medical Device NewCo For IP Due Diligence. Presentation available at knobbe.com/octane

Preparing Your Medical Device NewCo For IP Due Diligence. Presentation available at knobbe.com/octane Preparing Your Medical Device NewCo For IP Due Diligence Presentation available at knobbe.com/octane OCTANe Medical Device and Investor Forum October 23, 2013 The Panel Reza Zadno Venture Partner, InterWest

More information

Dr Lisa Bidwell Research Partnerships Manager, Faculty of Medicine February 2017

Dr Lisa Bidwell Research Partnerships Manager, Faculty of Medicine February 2017 Intellectual Property and Your Research Dr Lisa Bidwell Research Partnerships Manager, Faculty of Medicine February 2017 The role of RPMs Research Partnerships Managers (RPMs) are located within each of

More information

Where the brightest scientific minds thrive. IMED Early Talent and Post Doc programmes

Where the brightest scientific minds thrive. IMED Early Talent and Post Doc programmes Where the brightest scientific minds thrive. IMED Early Talent and Post Doc programmes Scientific innovation is at the heart of everything we do. Scientific innovation is at the heart of our business and

More information

Intellectual Property Overview

Intellectual Property Overview Intellectual Property Overview Sanjiv Chokshi, Esq. Assistant General Counsel For Patents and Intellectual Property Office of General Counsel Fenster Hall- Suite 480 (973) 642-4285 Chokshi@njit.edu Intellectual

More information

Davé Law Group s Unique Value Proposition

Davé Law Group s Unique Value Proposition Davé Law Group s Unique Value Proposition Davé Law Group (DLG) has 35 IP Professionals in India, 5 in the US and 2 in Japan DLG Offers Integrated Filing and Prosecution Capabilities in: United States India

More information

executives are often viewed to better understand the merits of scientific over commercial solutions.

executives are often viewed to better understand the merits of scientific over commercial solutions. Key Findings The number of new technology transfer licensing agreements earned for every $1 billion of research expenditure has fallen from 115 to 109 between 2004 and. However, the rate of return for

More information

Patenting and Protecting Early Stage R&D

Patenting and Protecting Early Stage R&D Patent Strategy for Startups Patenting and Protecting Early Stage R&D A Northworks IP Whitepaper By Peter Cowan, P.Eng., MBA Principal Consultant February 2014 IP STRATEGY Advisory > Innovation + Intellectual

More information